These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 10423582)

  • 1. [Controversial points in the treatment of patients with haematologic malignancies complicated with systemic fungal infections].
    Mori T
    Nihon Ishinkin Gakkai Zasshi; 1999; 40(3):143-9. PubMed ID: 10423582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fungal infections in nontransplant patients with hematologic malignancies.
    Segal BH; Bow EJ; Menichetti F
    Infect Dis Clin North Am; 2002 Dec; 16(4):935-64, vii. PubMed ID: 12512188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal infection from Fusarium spp. in children with refractory hematologic malignancies.
    Taçyildiz N; Yavuz G; Unal E; Gözdasoğlu S; Ertem M; Aysev D
    Med Pediatr Oncol; 1999 Dec; 33(6):596-7. PubMed ID: 10573590
    [No Abstract]   [Full Text] [Related]  

  • 5. Systemic fungal infections: major problems in cancer patients.
    Powles RL; Mehta J
    Indian J Cancer; 1994 Sep; 31(3):180-4. PubMed ID: 8557296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of itraconazole for systemic fungal infections complicated with hematological malignancies--multicenter cooperative study. West-Japan Systemic Fungal Infection Study Group].
    Shiku H; Horiuchi A; Kuramoto A; Harada M; Niho Y
    Kansenshogaku Zasshi; 1998 Nov; 72(11):1208-18. PubMed ID: 9884508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Invasive fungal infections in patients with hematological malignancies: a clinical approach].
    García-Ruiz JC; Pontón J
    Med Clin (Barc); 2000 Sep; 115(8):305-12. PubMed ID: 11093887
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic fungal infections in patients with hematologic malignancies: indications and limitations of the antifungal armamentarium.
    Böhme A; Karthaus M
    Chemotherapy; 1999; 45(5):315-24. PubMed ID: 10473919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EPICO 3.0. Empirical antifungal therapy in critically-ill hematology patients.
    Llinares P; Ruiz I; Zaragoza R; Ferrer R; Rodríguez AH; Maseda E; Grau S;
    Rev Iberoam Micol; 2016; 33(4):206-215. PubMed ID: 27751781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunistic mycoses in the immunocompromised host: experience at a cancer center and review.
    Anaissie E
    Clin Infect Dis; 1992 Mar; 14 Suppl 1():S43-53. PubMed ID: 1562695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genitourinary fungal infections: a therapeutic conundrum.
    Wise GJ
    Expert Opin Pharmacother; 2001 Aug; 2(8):1211-26. PubMed ID: 11584989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fungal infections in cancer patients: an escalating problem.
    Samonis G; Bafaloukos D
    In Vivo; 1992; 6(2):183-93. PubMed ID: 1525339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungal prophylaxis in neutropenic patients with hematologic malignancies: is there a real benefit?
    Böhme A; Karthaus M; Hoelzer D
    Chemotherapy; 1999; 45(3):224-32. PubMed ID: 10224346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on a concomitant therapy with fluconazole and human recombinant granulocyte colony stimulating factor in the treatment of systemic fungal infections with hematological disorders].
    Kitamura K; Miyagawa K; Urabe A; Sato H; Obayashi Y; Aoki I; Takaku F; Togawa A; Shindou E; Wakabayashi Y; Ohshima T; Horikoshi A; Nomura T; Ohki I; Suzuki K; Kamakura M; Oguchi A; Toyama K; Yaguchi M; Aoki N; Kato A; Mizoguchi H; Masuda M; Irie S; Fujioka S
    Jpn J Antibiot; 1996 Dec; 49(12):1062-72. PubMed ID: 9032593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.
    Clark NM; Grim SA; Lynch JP
    Semin Respir Crit Care Med; 2015 Oct; 36(5):767-85. PubMed ID: 26398542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluconazole vs low-dose amphotericin B for the prevention of fungal infections in patients undergoing bone marrow transplantation: a study of the North American Marrow Transplant Group.
    Wolff SN; Fay J; Stevens D; Herzig RH; Pohlman B; Bolwell B; Lynch J; Ericson S; Freytes CO; LeMaistre F; Collins R; Pineiro L; Greer J; Stein R; Goodman SA; Dummer S
    Bone Marrow Transplant; 2000 Apr; 25(8):853-9. PubMed ID: 10808206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New aspects in treatment of systemic mycoses].
    Presterl E; Graninger W
    Wien Klin Wochenschr; 1998 Nov; 110(21):740-50. PubMed ID: 9871965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal amphotericin B (AmBisome) for fungal infections in immunocompromised adults and children.
    Tollemar J; Klingspor L; Ringdén O
    Clin Microbiol Infect; 2001; 7 Suppl 2():68-79. PubMed ID: 11525221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.
    Boogaerts M; Winston DJ; Bow EJ; Garber G; Reboli AC; Schwarer AP; Novitzky N; Boehme A; Chwetzoff E; De Beule K;
    Ann Intern Med; 2001 Sep; 135(6):412-22. PubMed ID: 11560454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.